Preview

Rational Pharmacotherapy in Cardiology

Advanced search

THE ANALYSIS OF DIFFERENCES IN DOCTORS PREFERENCES IN THE PRESCRIPTIONS OF ANTIHYPERTENSIVE DRUGS IN FOUR REGIONS OF THE FAR EASTERN FEDERAL DISTRICT

https://doi.org/10.20996/1819-6446-2018-14-2-252-259

Full Text:

Abstract

Aim. To study regional features and preferences of specialists in the choice of drug therapy of arterial hypertension in four subjects of the Far Eastern Federal District.

Material and methods. Statistical data, demographic indicators, state and municipal drug procurements in Chukotka Autonomous Okrug, the Sakha Republic (Yakutia), the Magadan Region, and Kamchatka Krai were analyzed. The studied period was 2012-2016. Dynamics of the use (procurements) of five main therapeutic classes of antihypertensive drugs was studied.

Results. Among β-blockers the leaders were metoprolol (from 2% to 30.8%) and bisoprolol (from 2.4% to 20.3%); in group of angiotensin converting enzyme inhibitors – enalapril (from 3.6% to 27%), lisinopril (from 4.4% to 23.9%) and perindopril (from 0.9% to 7.8%); among calcium channel blockers – amlodipine (from 5.6% to 11.3%); in group of diuretics – indapamide (from 2.5% to 13%) and spironolactone (from 3% to 12.5%), and in group of angiotensin II antagonists – losartan (from 0.4% to 15.6%). Angiotensin converting enzyme inhibitors were the most used therapeutic class of antihypertensive drugs in Chukotka Autonomous Okrug, the Magadan region and Kamchatka Krai. At the same time, β-blockers accounted for more than a half of state and municipal procurements in the Sakha Republic (Yakutia).

Conclusion. It is necessary to study regional aspects and approaches to therapy to assess the extent and specificity of the implementation of research results, standards and recommendations in real clinical practice.

About the Authors

M. S. Soboleva
Far Eastern State Medical University
Russian Federation

Mariia S. Soboleva – PhD (Biology), Associate Professor, Chair of Pharmacy and Pharmacology

Muravyeva-Amurskogo ul. 35, Khabarovsk, 680000



Е. E. Loskutova
Peoples' Friendship University of Russia (RUDN University)
Russian Federation

Ekaterina E. Loskutova – PhD (Pharmacy), Professor, Head of Chair of Management and Economics of Pharmacy, Medical Institute

Miklukho-Maklaya ul. 6, Moscow, 117198



References

1. Demographic Yearbook of Russia. Moscow: Rosstat; 2017. (In Russ.)

2. Incidence of all population of Russia in 2015. Statistical materials. Part I. Moscow: TSNIIOIZ; 2016. (In Russ.)

3. Oganov R.G., Pogosova G.V., Koltunov I.E. et al. RELIPH Regular Treatment and Prevention The Key to Improvement of Situation With Cardiovascular Diseases in Russia: Results of Multicenter Study. Part I. Kardiologiia. 2007;5:58-66. (In Russ.)

4. Oganov R.G., Pogosova G.V., Koltunov I.E. et al. RELIPH Regular Treatment and Prevention The Key to Improvement of Situation With Cardiovascular Diseases in Russia: Results of Multicenter Study. Part II. Kardiologiia. 2007;11:30-9. (In Russ.)

5. Oganov R.G., Pogosova G.V., Koltunov I.E. et al. RELIPH Regular Treatment and Prevention The Key to Improvement of Situation With Cardiovascular Diseases in Russia: Results of Multicenter Study. Part III. Kardiologiia. 2008;4:46-53. (In Russ.)

6. Boytsov S.A., Balanova Yu.A., Shalnova S.A., Deev A.D. et al. Arterial hypertension among individuals of 25-64 years old: prevalence, awareness, treatment and control. By the data from ECCD. Cardiovascular Therapy and Prevention. 2014;13(4):4-14. (In Russ.)

7. Oganov R.G., Timofeeva T.N., Koltunov I.E. et al. Arterial hypertension epidemiology in Russia, the results of 2003-2010 federal monitoring. Cardiovascular Therapy and Prevention. 2011;1:9-13. (In Russ.)

8. Kalinina A.M., Boytsov S.A., Kushunina D.V. et al. Hypertension in the routine healthcare: Focus on the results of health check-up. Arterial'naya Gipertenziya. 2017;1:6-16. (In Russ.)

9. Chazova I.E., Oshepkova E.V., Zhernakova Yu.V. Clinical guidelines Diagnostics and treatment of arterial hypertension. Kardiologicheskij Vestnik. 2015;1:3-30. (In Russ.)

10. 2013 Practice guidelines for the management of arterial hypertension of the European Society of Hypertension (ESH) and the European Society of Cardiology (ESC): ESH/ESC Task Force for the Management of Arterial Hypertension. J Hypertens. 2013;31(10):1925-38. doi: 10.1097/HJH.0b013e328364ca4c.

11. IMS Health database. Analytics. Available at: http://int.imshealth.com. Checked by Feb 21, 2018. (In Russ.)

12. The register of the contracts concluded by customers. Available at: http://www.zakupki.gov.ru/epz/contract/quicksearch/search.html. Checked by Mar 07, 2018. (In Russ.)

13. The order of the Government of the Russian Federation from 12/28/2016 of № 2885-p «About the approval of the list of vital and essential drugs for 2017». The Collection of the legislation of the Russian Federation, 1/9/2017, №2 (Part II); Art. 435. (In Russ.)

14. The order of Ministry of Health Russian Federation on November 9, 2012 №708n «About the approval of the standard of primary health care at primary arterial hypertension (hypertension)». Russian Newspaper (special release). 07.06.2013;122/1. (In Russ.)

15. Leonova M.V., Belousov Yu.B., Shteinberg L.L. et al. The results of the pharmacoepidemiological study PIFAGOR IV concerning arterial hypertension (AH patients survey). Sistemnye Gipertenzii. 2015;12(3):11-8. (In Russ.)

16. Leonova M.V., Belousov Yu.B., Shteinberg L.L. et al. Results of pharmacoepidemiological study of arterial hypertension PIFAGOR III (poll of patients with AH). Sistemnye Gipertenzii. 2010;7(2):339. (In Russ.)

17. Adasheva T.V., Zadionchenko V.S., Fedorova I.V., Shakhrai N.B. Resistant vs uncontrolled arterial hypertension: management Сonsilium Medicum. 2017;19(5):20-5. (In Russ.)

18. Morozova T.E., Yudina I.Yu. Triple combination in the treatment of hypertension the real way to improve blood pressure control. Сonsilium Medicum. 2017;19(1):8-12. (In Russ.)

19. Liventseva M.M. Combined therapy with diuretic and angiotensin-converting enzyme inhibitor in a new strategy for the treatment of hypertension. Mezhdunarodnye Obzory: Klinicheskaya Praktika I Zdorov'e. 2017;2(25):66-74. (In Russ.)

20. Baida A., Pozdnyakova O., Baida K., Peregudova L. Fixed-dose triple combination of antihypertensive drugs for hypertension. Vrach. 2017;6:38-40. (In Russ.)

21. Kartasheva Y.D., Vinogradov O., Zamyatin M. N. Fixed-dose drug combinations for blood pressure control. Klinicheskaya Patofiziologiya. 2017;23(1):32-9. (In Russ.)

22.


For citation:


Soboleva M.S., Loskutova Е.E. THE ANALYSIS OF DIFFERENCES IN DOCTORS PREFERENCES IN THE PRESCRIPTIONS OF ANTIHYPERTENSIVE DRUGS IN FOUR REGIONS OF THE FAR EASTERN FEDERAL DISTRICT. Rational Pharmacotherapy in Cardiology. 2018;14(2):252-259. (In Russ.) https://doi.org/10.20996/1819-6446-2018-14-2-252-259

Views: 171


Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 License.


ISSN 1819-6446 (Print)
ISSN 2225-3653 (Online)